ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Reduction of Abdominal Obesity and Insulin Resistance in Women

This study has been completed.

Sponsors and Collaborators: Queen's University
Canadian Institutes of Health Research (CIHR)
Information provided by: Queen's University
ClinicalTrials.gov Identifier: NCT00664495
  Purpose

The purpose of the study was to assess the effects of equivalent diet- or exercise-induced weight loss and related insulin resistance in abdominally obese women.


Condition Intervention
Obesity
Behavioral: Diet Weight Loss
Behavioral: Exercise Weight Loss
Behavioral: Exercise Without Weight Loss

MedlinePlus related topics:   Exercise and Physical Fitness    Obesity    Weight Control   

ChemIDplus related topics:   Insulin   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Parallel Assignment
Official Title:   Reduction of Abdominal Obesity and Insulin Resistance in Women

Further study details as provided by Queen's University:

Primary Outcome Measures:
  • Abdominal Obesity [ Time Frame: 4 months ] [ Designated as safety issue: No ]
  • Insulin Resistance [ Time Frame: 4 Months ] [ Designated as safety issue: No ]

Study Start Date:   April 1999
Study Completion Date:   December 2003
Primary Completion Date:   December 2003 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
C: No Intervention
Control
DWL: Active Comparator
Diet Weight Loss
Behavioral: Diet Weight Loss
EWL: Active Comparator
Exercise Weight Loss
Behavioral: Exercise Weight Loss
EWS: Active Comparator
Exercise Without Weight Loss
Behavioral: Exercise Without Weight Loss

  Eligibility
Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Premenopausal women

Exclusion Criteria:

  • Smokers and diabetics
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00664495

Locations
Canada, Ontario
Queen's University    
      Kingston, Ontario, Canada, K7L 3N6

Sponsors and Collaborators
Queen's University
Canadian Institutes of Health Research (CIHR)

Investigators
Principal Investigator:     Robert Ross, PhD     Queen's University    
  More Information

Publications of Results:

Responsible Party:   ( Queen's University )
Study ID Numbers:   Ross 1999
First Received:   April 21, 2008
Last Updated:   April 22, 2008
ClinicalTrials.gov Identifier:   NCT00664495
Health Authority:   Canada: Canadian Institutes of Health Research

Keywords provided by Queen's University:
Obesity, exercise, diet, insulin resistance  

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
Hyperinsulinism
Obesity
Metabolic Diseases
Nutrition Disorders
Overweight
Overnutrition
Insulin Resistance
Metabolic disorder
Glucose Metabolism Disorders
Insulin

ClinicalTrials.gov processed this record on August 20, 2008




Links to all studies - primarily for crawlers